OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

HTML

Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: British Journal of Ophthalmology
DOI: 10.1136/bjophthalmol-2012-302391
Authors: Ilse Krebs, Leopold Schmetterer, Agnes Boltz, Reinhard Told, Veronika Vécsei-Marlovits, Stefan Egger, Ulrich Schönherr, Anton Haas, Siamak Ansari-Shahrezaei, Susanne Binder
Institutions: Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Medical University of Vienna, Klinik Hietzing, University of Salzburg, Convent Hospital of the Brothers of Saint John of God, Medical University of Graz
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: neovascular age-related macular degeneration, ranibizumab, bevacizumab, anti-VEGF therapy, visual acuity, retinal thickness, lesion size, treatment-naive patients, adverse events, drug comparison
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2053567993
FWCI: 26.17
Cites: 25
Cited by: 206
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security